We are live on ! Find out more
CBAY

Cymabay Therapeutics
CBAY

Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

118 hedge funds and large institutions have $755M invested in Cymabay Therapeutics in 2018 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 34

30% more call options, than puts

Call options by funds: $640K | Put options by funds: $491K

29% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 28

20% more capital invested

Capital invested by funds: $627M → $755M (+$128M)

10% more funds holding

Funds holding: 107 → 118 (+11)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
118
Holders Change
+11
Holders Change %
+10.28%
% of All Funds
2.7%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
45
Increased
36
Reduced
28
Closed
34
Calls
$640K
Puts
$491K
Net Calls
+$149K
Net Calls Change
-$906K

Top Buyers

1
BlackRock
BlackRock
New York
+$36.1M
2
EAM
Eagle Asset Management
Florida
+$25.8M
3
CTA
Carillon Tower Advisers
Florida
+$18.1M
4
ACA
Avoro Capital Advisors
New York
+$16M
5
State Street
State Street
Massachusetts
+$13.6M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$39.7M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$12.5M
3
BC
Boxer Capital
California
-$7.75M
4
FCM
Farallon Capital Management
California
-$7.14M
5
Goldman Sachs
Goldman Sachs
New York
-$4.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
151
Federated Hermes
Pennsylvania
– -$2K -172 Closed
TWA
152
TCI Wealth Advisors
Arizona
– +$338 +27 New
3 4 5 6
7